Significant Corporate Developments: WALNUC (09981) set its final offer price at HK$20.09 per share. Hengrui Pharmaceuticals (01276) announced that its injectable Ruikang Trastuzumab has been included in the list of breakthrough therapy drugs. Baiyunshan (00874) confirmed that its Sodium Penicillin for Injection has passed generic drug consistency evaluation. China Hanking (03788) has been added to the MSCI China Small Cap Index. PuDa Technology (00650) successfully delivered a 12-inch high-temperature sulfuric acid cleaning equipment unit to a customer. Sheng Bella (02508) reported major progress in its global expansion strategy, with plans to enter the Eastern United States, the UK, France, Thailand, and Australia. Global New Materials International (06616) participated in establishing a partnership to acquire a 29.89% stake in Zhejiang Jihua (603980.SH). Trading will resume on February 12. GUANZE MEDICAL (02427) received a cash offer from Fude (HK) Investment Holdings at a discount of approximately 84.0%. Trading will resume on February 12.

Operating Results: Manulife Financial-S (00945) disclosed its 2025 annual results, reporting core earnings of CAD 7.5 billion. Budweiser Brewing Company APAC (01876) released its 2025 results, with profit attributable to equity holders at USD 489 million, down 32.6% year-on-year. NetEase-S (09999) announced its 2025 performance, with net profit attributable to shareholders reaching approximately RMB 33.76 billion, an increase of 13.68% year-on-year. NetEase Music (09899) reported its 2025 results, with adjusted net profit of approximately RMB 2.86 billion, up 68.2% year-on-year. China Resources Power (00836) recorded sales of electricity from its affiliated power plants in January at 23,788.79 GWh, an increase of 28.4% compared to the same period last year. Q Technology (01478) sold 41.482 million handset camera modules in January, down 3.7% month-on-month but up 19.5% year-on-year. FriendTimes (06820) issued a profit alert, expecting a net profit between RMB 90 million and RMB 96 million for 2025, reversing from a loss to a profit.

For more updates on Hong Kong stocks, download the Zhitong Finance app. Additional information on Hong Kong and overseas wealth management is available at www.zhitongcaijing.com. To join a Hong Kong stock investment group, add the Zhitong customer service WeChat account (ztcjkf).